Cargando…
Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment
Inflammatory bowel disease (IBD) is a chronic disease of unknown etiology which mostly involves the intestine and requires a personalized approach for treatment. IBD represents a heterogeneous group of patients with inherently variable disease courses. Hence, the heterogeneity of patient populations...
Autores principales: | Norouzinia, Mohsen, Chaleshi, Vahid, Alizadeh, Amir Houshang Mohammad, Zali, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660264/ https://www.ncbi.nlm.nih.gov/pubmed/29118930 |
Ejemplares similares
-
Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2021) -
Cholangitis: Diagnosis, Treatment and Prognosis
por: Mohammad Alizadeh, Amir Houshang
Publicado: (2017) -
Evaluation of IL-12A, IL-12B, IL-23A and IL-27 mRNA expression level genes in peripheral mononuclear cells of inflammatory bowel disease patients in an Iranian population
por: Norouzinia, Mohsen, et al.
Publicado: (2018) -
Introduction of inflammatory bowel disease biomarkers panel using protein-protein interaction (PPI) network analysis
por: Asadzadeh-Aghdaee, Hamid, et al.
Publicado: (2016) -
Toll-Like Receptor 7 a Novel Non-Invasive Inflammatory Genetic Sensor for Ulcerative Colitis Remission Monitoring
por: Asadzadeh-Aghdaei, Hamid, et al.
Publicado: (2023)